Relmada Therapeutics, Inc.
Clinical trials sponsored by Relmada Therapeutics, Inc., explained in plain language.
-
Bladder cancer drug trial pulled before starting
Disease control TerminatedThis was a planned Phase 3 study testing a drug called NDV-01 (a slow-release combination of two chemotherapy drugs) for people with a type of bladder cancer that did not respond to standard BCG treatment. The goal was to see if the drug could make the cancer disappear, but the s…
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 08:50 UTC
-
Bladder cancer drug trial halted before it began
Disease control TerminatedThis study was designed to test if a new drug called NDV-01 could keep bladder cancer from returning after surgery. It was for people with intermediate-risk non-muscle invasive bladder cancer. However, the trial was withdrawn before enrolling any participants, so no results are a…
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC